Jupiter Life Line Hospitals Ltd

Jupiter Life Lin Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Jupiter Life Line Hospitals Ltd

₹ 1,327 0.08%
29 May - close price
jupiterhospital.com BSE: 543980 NSE: JLHL
About

Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]

Key Points

Hospital Portfolio:[1][2]
The company operates 4 hospitals across Thane, Pune, Indore & Dombivli with 1,248 operational beds (Census Beds and Non-Census Beds: 140).

Website BSE NSE
  • Market Cap ₹ 8,683 Cr.
  • Current Price ₹ 1,327
  • High / Low ₹ 1,625 / 1,152
  • Stock P/E 43.9
  • Book Value ₹ 236
  • Dividend Yield 0.08 %
  • ROCE 15.4 %
  • ROE 13.6 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 145% CAGR over last 5 years

Cons

  • Working capital days have increased from 24.3 days to 97.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
242 243 263 273 291 289 335 333 337 353 394 365 388
191 190 202 211 228 223 257 256 257 275 301 282 299
Operating Profit 52 53 61 62 63 65 78 76 80 78 92 83 89
OPM % 21% 22% 23% 23% 22% 23% 23% 23% 24% 22% 23% 23% 23%
1 4 3 8 10 7 7 7 7 13 11 3 11
Interest 11 12 12 1 1 1 1 3 6 8 8 8 9
Depreciation 10 11 11 11 10 11 14 14 18 21 21 22 23
Profit before tax 32 34 41 58 62 60 70 67 63 62 74 57 68
Tax % 51% -60% 19% 25% 27% 26% 26% 22% 28% 29% 23% 25% 26%
16 54 34 44 45 45 52 52 45 44 57 42 50
EPS in Rs 2.79 9.55 5.14 6.66 6.87 6.78 7.88 7.94 6.89 6.69 8.75 6.49 7.66
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
463 486 733 893 1,073 1,262 1,500
379 419 580 691 831 965 1,157
Operating Profit 84 67 153 201 242 297 343
OPM % 18% 14% 21% 23% 23% 24% 23%
0 4 4 8 22 29 37
Interest 26 39 44 42 26 11 33
Depreciation 26 31 36 39 42 57 88
Profit before tax 33 2 77 129 195 258 260
Tax % 10% 248% 34% 43% 10% 25% 25%
30 -2 51 73 177 194 194
EPS in Rs 5.83 -0.45 10.05 12.90 26.94 29.51 29.59
Dividend Payout % 0% 0% 0% 0% 4% 3% 3%
Compounded Sales Growth
10 Years: %
5 Years: 25%
3 Years: 19%
TTM: 19%
Compounded Profit Growth
10 Years: %
5 Years: 145%
3 Years: 39%
TTM: 5%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: -8%
Return on Equity
10 Years: %
5 Years: 17%
3 Years: 16%
Last Year: 14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 51 51 51 57 66 66 66
Reserves 186 188 243 309 1,103 1,291 1,479
272 426 495 469 0 393 584
94 124 120 151 112 155 255
Total Liabilities 603 789 909 986 1,281 1,905 2,383
435 630 684 720 718 977 1,384
CWIP 10 26 27 29 74 185 129
Investments 2 7 3 2 17 114 486
156 126 195 235 473 628 384
Total Assets 603 789 909 986 1,281 1,905 2,383

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
74 123 137 176 115 253 268
-43 -295 -84 -94 -246 -209 -442
-32 184 32 -51 128 301 136
Net Cash Flow -1 12 85 31 -3 345 -38
Free Cash Flow 46 -118 46 100 29 -67 -234
CFO/OP 106% 198% 95% 97% 68% 108% 97%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 35 16 14 19 19 12 18
Inventory Days 64 48 39 44 41 38 49
Days Payable 268 217 157 164 120 163 121
Cash Conversion Cycle -169 -152 -104 -101 -59 -113 -54
Working Capital Days 17 -7 -24 -24 -5 -20 97
ROCE % 7% 17% 21% 22% 18% 15%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
ALOS (Average Length of Stay)
Days

Log in to view insights

Please log in to see hidden values.

Login
ARPOB (Average Revenue Per Occupied Bed)
INR
Average Occupancy Rate
%
Operational Bed Capacity
Number of Beds
Doctor Strength
Numbers
Inpatient Volume
Numbers
Outpatient (OPD) Volume
Numbers

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91% 40.91%
4.62% 3.96% 4.17% 6.06% 8.84% 10.04% 10.04% 9.77% 9.06% 8.48% 8.48%
12.69% 13.92% 14.16% 13.85% 13.46% 15.75% 15.64% 15.82% 16.97% 17.44% 17.01%
41.80% 41.19% 40.76% 39.18% 36.79% 33.31% 33.43% 33.51% 33.08% 33.17% 33.60%
No. of Shareholders 54,78239,34835,10735,79734,08133,91433,95634,19234,36133,62032,985

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls